Akademik Kurul Üyesi / Konuşmacı / Oturum Başkanı / Panelist / Eğitmen / Canlı Cerrahi de Operatör olarak Katıldığı Toplantılar:

1. Üriner Sistem Taş Hastalıkları Retrograd Intrarenal Cerrahi (RIRC) Kursu, 8-9 Ocak 2016, İzmir Üniversitesi “RİRC Endikasyonları ve kontrendikasyonları ” (Davetli Konuşmacı) “RİRC canlı vakalar ve makette çalışmalar” (Eğitmen, Canlı Cerrah) (Konuşmacı, Eğitmen, Cerrah)
2. Prostat Hastalıkları Benign Prostat Hiperplazisi Tedavisi Holmium Lazer ile Prostat Enüklasyonu (HOLEP) Canlı Cerrahi Kursu, 6 Şubat 2016, İzmir Üniversitesi ( Davetli Konuşmacı)
3. Bölgesel Retrograd İntrarenal Cerrahi Kursu, TÜAK, TÜD, Endoüroloji Derneği işbirliği ile, 15 Temmuz 2016, İzmir, Türkiye, (Konuşmacı, Eğitmen, Canlı Cerrah)
4. Üriner Sistem Taş Hastalıkları 2. Retrograd Intrarenal Cerrahi (RIRC) Kursu, 10-11 Şubat 2017, İzmir, Türkiye. “RİRC de bugün nerede kılavuzlar ne diyor? rirc 2 cm üzerindeki  taşlarda başarısı ve geleceği , anomalili böbreklerde rirc ” (Davetli Konuşmacı) “RİRC canlı vakalar ve makette çalışmalar” (Konuşmacı, Eğitmen, Canlı Cerrah)
5. Retrograd İntrarenal Cerrahi Kursu ,10-11 Mart 2017, Isparta, Türkiye. (Davetli Konuşmacı, Eğitmen, Cerrah)
6. Bölgesel Retrograd İntrarenal Cerrahi Kursu, TÜAK, TÜD, Endoüroloji Derneği işbirliği ile, 17 Mart 2017, İzmir, Türkiye (Davetli Konuşmacı, Eğitmen, Canlı Cerrah)
7. Laparoskopik Böbrek Cerrahisi Uygulamalı Kursu, 7-8 Nisan 2017, İzmir, Türkiye. (Konuşmacı, Eğitmen)
8. 2.Laparoskopik Böbrek Cerrahisi Uygulamalı Kursu, 22-23 Aralık 2017, İzmir, Türkiye. (Konuşmacı, Eğitmen)
9. Bölgesel Retrograd İntrarenal Cerrahi Kursu, TÜAK, TÜD, Endoüroloji Derneği işbirliği ile, 9 Şubat 2018, İzmir, Türkiye (Davetli Konuşmacı, Eğitmen, Canlı Cerrah)
10. Retrograd Intrarenal Cerrahi Kursu, 7 Nisan 2018, Pamukkale Üniversitesi, Denizli. (Davetli Konuşmacı, Eğitmen, Canlı Cerrah)
11. İnternational Symposium on Reproductive Health and İnfertility in May 4-5 ,2018 Baku,Azerbaijan (Davetli Konuşmacı)
12. Bölgesel Retrograd İntrarenal Cerrahi Kursu, TÜAK, TÜD, Endoüroloji Derneği işbirliği ile, 14 Eylül 2018, İzmir, Türkiye (Davetli Konuşmacı, Eğitmen, Canlı Cerrah)
13. 8. Ulusal Üreme Sağlığı ve İnfertilite  Kongresi (TSRM 2018) 8-11 Kasım 2018 ,Antalya ''Varikosel ve Erkek İnfertilitesi ''(Davetli Knuşmacı)
14. Retrograd Intrarenal Cerrahi Kursu, 6 Nisan 2019, İzmir, Türkiye. (Davetli Konuşmacı, Eğitmen, Canlı Cerrah)
15. Retrograd Intrarenal Cerrahi Kursu, 22 Haziran 2019, Süleyman Demirel Üniversitesi, Isparta Türkiye. (Davetli Konuşmacı, Eğitmen)
16. Bölgesel Retrograd İntrarenal Cerrahi Kursu, TÜAK, TÜD, Endoüroloji Derneği işbirliği ile, 20 Eylül 2019, İzmir, Türkiye (Davetli Konuşmacı, Eğitmen, Canlı Cerrah)

Uluslararası hakemli dergilerde yayımlanan makaleler :

1. Akdemir S, Gurocak S, Konac E, Ure I, Onen HI, Gonul II, Sozen S, Menevse A. Different surgical techniques and L-carnitine supplementation in an experimental  varicocele model. Andrologia. 2013 Oct 10. doi: 10.1111/and.12172. [Epub ahead ofprint]
2. Karabakan M, Akdemir S, Akdemir AO, Erkmen AE, Kayabas U. A rare case of prostatic brucellosis mimicking prostate cancer. Urol J. 2014 Nov 30;11(6):1987-8. PubMed PMID: 25433480.
3. Association between serum folic acid level and erectile dysfunction.Karabakan M, Erkmen AE, Guzel O, Aktas BK, Bozkurt A, Akdemir S.Andrologia. 2016 Jun;48(5):532-5. doi: 10.1111/and.12474. Epub 2015 Aug 25.PMID: 26302884
4. Karabakan Mehmet,Bozkurt Alıseydı,Hırık Erkan,Çelebı Bülent,Akdemır Serkan, Güzel Özer,Nuhoglu Barıs (2016). The Prevalence Of Premature Ejaculation İn Young Turkish Men. Andrologia, Doi: 10.1111/And.12529
5. Karabakan M, Keskin E, Akdemir S, Bozkurt A. Effect Of Tadalafil 5mg Daily Treatment On The Ejaculatory Times, Lower Urinary Tract Symptoms And Erectile Function İn Patients With Erectile Dysfunction. Int Braz J Urol. 2016 Nov 2. Doi:10.1590/S1677-5538.IBJU.2016.0376.
6. Karabakan M, Bozkurt A, Akdemir S, Gunay M, Keskin E. Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study. Int J Impot Res. 2017 Apr 20. doi:10.1038/ijir.2017.19. PubMed PMID: 28424502.
7. Differences in Poly(ADP-ribose) Polymerase1- (PARP1-) and Proliferative Cell Nuclear Antigen (PCNA) Immunoreactivity in Patients Who Experienced Successful and Unsuccessful Microdissection Testicular Sperm Extraction Procedures.Akarsu S, Büke B, Gürgen SG, Akdemir S, Gode F, Biçer M, Tekindal MA, Isik AZ.Urol J. 2017 Aug 29;14(5):5018-5022.PMID: 28853108 

Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler :

1. Akdemir S., Gürocak O.S., Konac E., Üre İ, Önen İ, Gönül I, Sözen S., Menevse A. “The Impact of L-carnitine and Surgical Techniques on Spermatogenesis in an Experimental varicocele model”. S64, Eur Urol Suppl 2012;1,1 (4):148. Abstracts of EAU 12th Central European Meeting (CEM), 12-13 October 2012, Dresden,Germany
2. Mehmet Karabakan,Serkan Akdemir, Alp Özgür Akdemir,Çetin Volkan Öztekin, Özer Güzel, Cevdet Serkan Gökkaya,Mesut Çetinkaya. ‘’ The Effect Of Ejeculation Frequency on Serum Prostate Specific Antigen Level’’.J Urol Suppl 191;(4S):e862. AUA Annual Meeting 2014 Abstracts, 16-21 May 2014, Orlando,USA
3. M.Arslan,S.Akdemir,C.Guler. Continence outcomes after bladder neck sparing during laparoscopic radical prostatectomi. EAU 11th South Eastern European Meeting 6-8 November 2015. Antalya ,Turkey
4. M.Arslan,S.Akdemir,C.Guler.Our retrograde intrarenal surgery experience: The 100 cases. EAU 11th South Eastern European Meeting 6-8 November 2015. Antalya ,Turkey

Yazılan ulusal / uluslararası kitaplardaki bölümler

1. Serkan Akdemir, Murat Arslan. Mesane kanserinin moleküler biyolojisi ve gen mutasyonları. Mesane Kanseri Güncelleme. p.1-11. Editör:Doç Dr Altuğ Tuncel. Nobel 2015. ISBN:978-975-00112-7-6

Ulusal hakemli dergilerde yayımlanan makaleler :

1. Serkan Akdemir, Mehmet Karabakan, Alp Özgür Akdemir. Laterally Rotated Kidney. JCAM,Published online,22/01/2013.DOİ:10.4328/JCAM.1487.
2. Harun Türel,Mehmet Karabakan, Serkan Akdemir.Giant Ureter Stone. JCAM,Published online,30/05/2013.DOİ:10.4328/JCAM.1911.
3. Mehmet Karabakan,Serkan Akdemir,Alp Özgür Akdemir,Sezer Kulaçoğlu,Mesut Çetinkaya. Primary Renal Carcinoid Tumor: A Case Report. JCAM, Published Online, 08/04/2014.DOI:10.4328/JCAM.2411
4. Mehmet Karabakan,Özer Güzel,Akif Ersoy Erkmen, Remzi Salar, Aliseydi Bozkurt, Serkan Akdemir. Nörobehçet Hastalığına Bağlı Gelişen Nörojen Mesane: Olgu Sunumu. JAREM 2014;1:28-30 doi:10.5152/jarem2014.427
5. İyimser Üre, Serkan Akdemir, Serhat Gürocak, Sinan Sözen.Açık Kolposüspansiyondan On yıl Sonra Görülen Mesane Taşı: Olgu Sunumu. Osmangazi Tıp Dergisi Mayıs 2013; 35(2) 37-40
6. Mehmet Karabakan, Serkan Akdemir, Alp Özgür Akdemir, Özer Güzel, Aysel Çolak. Nadir Bir Olgu Sunumu: Mesanenin Plazmasitoid Ürotelyal  Karsinomu.JCAM Published Online, 17/05/2014. DOİ:10.4328/jcam.2625
7. Mehmet Karabakan, Serkan Akdemir, Alp Özgür Akdemir, Çetin Volkan Öztekin, Özer Güzel, Cevdet Serkan Gökkaya, Mesut Çetinkaya, The effect of ejaculation frequency on serum prostate spesific antigen level, JRM-685, JAREM
8. Mehmet Karabakan, Alp Özgür Akdemir, Çetin Volkan Öztekin, Özge Han, Serkan Akdemir. Well-Differentiated Scrotal Liposarcoma, İnönü Üniversitesi Sağlık Bilimleri Dergisi 2014; 3 (1): 43-44 ISSN:2146-6696
9. TÜREL HARUN,KARABAKAN MEHMET,AKDEMIR SERKAN (2015). GiantUreter Stone: Original Image. Journal of Clinical and Analytical Medicine, 6(4), Doi:10.4328/JCAM.1911
10. AKDEMIR SERKAN,KARABAKAN MEHMET,AKDEMIR ALP ÖZGÜR (2015). Lateral Rotated Kidney with Uretero Pelvic Junction Obstruction. Journal of Clinical and Analytical Medicine, 6(2), Doi: 10.4328/JCAM.1487

Ulusal bilimsel toplantılarda sunulan ve bildiri kitaplarında (proceedings) basılan bildiriler:

1. Serkan Akdemir, Tevfik Sinan Sözen, Özdemir Serhat Gürocak, Cenk Acar, Ali Furkan Batur,İyimser Üre, İbrahim Bozkırlı., “Hormon Refrakter Prostat Kanserinde Docetaxel ve Prednizon Kemoterapisi”. 20. Ulusal Üroloji Kongresi, Kongre Özet Kitabı; S.323, P-312. Antalya (2008).
2. Ali Furkan Batur, Sinan Sözen, Serhat Gürocak, İyimser Üre, Lokman Irkılata, Serkan Akdemir. “Prostat Kanseri Tedavisinde Kriyoterapi:Klinik Tecrübemiz”. 1. Ulusal Ürolojik Cerrahi Kongresi, S7-7,(sayfa 240),Antalya Ekim 2012.
3. Serkan Akdemir, Lokman Irkılata, İyimser Üre, Ali Furkan Batur,Bora Küpeli, Sinan Sözen. “Küçük böbrek tümörlerinin tedavisinde açık ve laparoskopik parsiyel nefrektomi”. 1. Ulusal Ürolojik Cerrahi Kongresi, S 8-9,(sayfa 281),Antalya Ekim 2012.
4. Serkan Akdemir, Serhat Gürocak,Ece Konaç, İyimser Üre, İlke Önen, İpek Işık Gönül, Sinan Sözen,Adnan Menevşe. ” Deneysel Varikosel Modelinde Uygulanan Cerrahi Teknik ve L-Karnitin Tedavisinin Spermatogenez Üzerine Etkisi”. 1. Ulusal Ürolojik Cerrahi Kongresi, S12-4,(sayfa 367),Antalya Ekim 2012.
5. Mehmet Karabakan, Özer Güzel, Serkan Akdemir, Alp Özgür Akdemir,”Erektil Disfonksiyon ile Folik Asit Düzeyi Arasındaki Ilişki”. 10. Ulusal Androloji Kongresi, P08,(sayfa 135), Bodrum Haziran 2013.
6. Mehmet Karabakan,  Akif Ersoy Erkmen,  Özer Güzel,  Binhan Kağan Aktaş, Aliseydi Bozkurt, Serkan Akdemir,  Erektil disfonksiyonlu hastalar ile sağlıklı erkekler arasında serum folik asit düzeylerinin karşılaştırılması, 11. Ulusal Androloji Kongresi, 30 Nisan – 3 Mayıs 2015 Fethiye, Muğla
7. Mehmet Karabakan, Aliseydi Bozkurt, Erkan Hirik, Bülent Çelebi, Serkan Akdemir, Barış Nuhoğlu, Genç Türk Erkeklerinde Prematüre Ejakülasyon Prevelansı11. Ulusal Androloji Kongresi, 30 Nisan – 3 Mayıs 2015 Fethiye, Muğla
8. Karabakan M, Akdemir S, Akdemir AO, Erkmen AE, Kayabas U, Prostat kanserini taklit eden nadir bir prostat Brusellozu olgusu, 23. Ulusal Üroloji Kongresi, 16-19 Ekim 2014 Antalya
9. Mehmet Karabakan, Ercüment Keskin, Serkan Akdemir, Aliseydi Bozkurt, Erektil isfonksiyon Hastalarında Günde Bir Kez Tadalafil 5 mg Tedavisinin Ejakülasyon Süresine Etkisi, 3. Ürolojik Cerrahi Kongresı,2016
10. Karabakan Mehmet, Bozkurt Alıseydı, ,Akdemır Serkan,Ercüment Keskin Erektil Disfonksiyon Hastalarında Serum Endocan Düzeyinin Önemi - Significance Of Serum Endocan Level In Patients With Erectile Dysfunction. . 3. Ürolojik Cerrahi Kongresı,2016
11. Murat Arslan, Serkan Akdemir,BPH tedavisinde Holep Tecrübemiz: İlk 100 Vaka Poster Sunum 27. Ulusal Üroloji Kongresi 26-29 Ekim 2018 Kıbrıs
12. Murat Arslan , Serkan Akdemir, Laparoskopik Ekstraperitoneal İnguinal Herni Onarımı. Videosunum 27. Ulusal Üroloji Kongresi 26-29 Ekim 2018 Kıbrıs
13. Murat Arslan, Serkan Akdemir, BPH tedavisinde Holep Video sunum 27. Ulusal Üroloji Kongresi 26-29 Ekim 2018 Kıbrıs

GÖREV ALDIĞI BÖLÜMLER

ÜROLOJİ

Perioperative, Oncological, and Functional Outcomes after Retroperitoneal Laparoscopic Partial Nephrectomy in Elderly Patients: A Propensity Score Matching Analysis

By

Karamik, K (Karamik, Kaan) [1] ; Anil, H (Anil, Hakan) [2] ; Yildiz, A (Yildiz, Ali) [3] ; Güzel, A (Guzel, Ahmet) [4] ; Akdemir, S (Akdemir, Serkan) [5] ; Arslan, M (Arslan, Murat) [3]

 (provided by Clarivate) 

Source

Volume34Issue10Page915-920

DOI10.1089/lap.2024.0234

Published

OCT 1 2024

Early Access

AUG 2024

Indexed

2024-09-06

Document Type

Article

Jump to

Abstract

Purpose: We aimed to assess the perioperative, oncological, and functional outcomes of patients aged 70 years or older following retroperitoneal laparoscopic partial nephrectomy (LPN) and compare their results with younger patients. Materials and Methods: A retrospective review of our prospectively maintained database identified 329 patients who underwent retroperitoneal LPN from January 2013 to October 2022. The patients divided into 2 groups defined by age >= 70 or <70 years at the time of surgery. A propensity score matching analysis was conducted to obtain two balanced groups. The groups were compared for safety (perioperative outcomes) and efficacy (oncological and functional outcomes). Results: After matching, all variables were well balanced with no differences between the two cohorts. No significant differences were found in perioperative outcomes, including operative time, warm ischemia time, blood loss, hospital stay, and complications (P values >.05). Concerning functional outcomes, postoperative glomerular filtration rate and decrease in glomerular filtration rate were significantly better in the younger group compared with the elderly groups (P = .003 and P = .001, respectively). Although margin, ischemia, complications rates were similar between the cohorts (P = .068), Pentafecta rates were lower in the elderly patients (P = .029). In terms of oncological outcomes, recurrence-free survival and cancer-specific survival were comparable between the groups. Conclusion: Retroperitoneal LPN can be performed safely and with adequate oncological efficacy in elderly patients.

Keywords

Elderly, Retroperitoneal, Partial nephrectomy, Laparoscopy, Renal cell carcinoma

Assisted partial nephrectomy, Small renal masses, Transperitoneal, Cohort

UPGRADE score: a new scoring system in predicting pathological upgrading after prostatectomy in patients with Gleason grade group 1 prostate cancer

By

Karamik, K (Karamik, Kaan) [1] ; Anil, H (Anil, Hakan) [2] ; Yildiz, A (Yildiz, Ali) [3] ; Guezel, A (Guezel, Ahmet) [4] ; Akdemir, S (Akdemir, Serkan) [5] ; Arslan, M (Arslan, Murat) [3]

 (provided by Clarivate) 

Source

JOURNAL OF MENS HEALTH

Volume20Issue10Page111-116

DOI10.22514/jomh.2024.171

Published

OCT 2024

Indexed

2024-11-19

Document Type

Article

Jump to

Abstract

Pathological upgrading poses a significant challenge in treatment decision-making, particularly for patients considered for active surveillance (AS). This study aimed to devise a novel scoring system to predict the risk of upgrading in patients with biopsy Gleason grade group 1 prostate cancer. We conducted a retrospective review of 235 patients who underwent radical prostatectomy between February 2014 and June 2022. Data on patient age, prostate-specific antigen (PSA) level, body mass index, clinical T-stage, prior biopsy history, Prostate Imaging-Reporting and Data System (PIRADS) score, time interval from biopsy to surgery, and pathological outcomes were collected. After a comprehensive review of the literature, multivariate analyses identified seven factors associated with upgrading in prostate cancer patients after radical prostatectomy: uninformative prior biopsy sample, PSA level, greatest percentage of tumor involvement, radiological PIRADS score, age, delay from biopsy to surgery and extension of positive cores. These factors were integrated into our devised U.P.G.R.A.D.E. model to form a scoring system. The U.P.G.R.A.D.E. score was calculated based on the cumulative score of these variables. The predictive performance of the U.P.G.R.A.D.E. scoring system was assessed, revealing a cohort with a mean age of 64.22 +/- 5.88 years and a mean PSA value of 8.92 +/- 5.05 ng/mL. The pathological samples of 95 patients (40.6%) were upgraded, and the upgraded patients exhibited significantly higher U.P.G.R.A.D.E. scores (p <0.001). The area under the receiver operating characteristic (AUROC) curve for the U.P.G.R.A.D.E. scoring system demonstrated robust predictive ability for upgrading (AUROC = 0.952; 95% Confidence interval (CI): 0.926-0.978; p < 0.001). In addition, a higher U.P.G.R.A.D.E. score was strongly associated with an increased risk of upgrading in biopsy Gleason grade group 1 patients, suggesting potential limitations for active surveillance eligibility in these individuals. Further validation studies are warranted to confirm these initial findings.

Keywords

Author Keywords Prostate cancer, Pathology, Upgrading, Scoring system

Predictive factors affecting morcellation efficiency in holmium laser enucleation of the prostate

By

Anil, H (Anil, Hakan) [1] , [6] ; Güzel, A (Guzel, Ahmet) [2] ; Yildiz, A (Yildiz, Ali) [3] ; Akdemir, S (Akdemir, Serkan) [4] ; Karamik, K (Karamik, Kaan) [5] ; Arslan, M (Arslan, Murat) [3]

 (provided by Clarivate) 

Source

INVESTIGATIVE AND CLINICAL UROLOGY

Volume64Issue4Page388-394

DOI10.4111/icu.20220361

Published

JUL 2023

Indexed

2023-08-19

Document Type

Article

Jump to

Abstract

Purpose: To determine the factors affecting morcellation efficiency in holmium laser enucleation of the prostate (HoLEP) surgery.Materials and Methods: Patients who underwent HoLEP surgery by a single surgeon between 2018 and 2022 were included in the study. Our primary outcome of interest in this study was morcellation efficiency. The effect of preoperative and perioperative variables on morcellation efficiency was evaluated with linear regression analysis. Results: A total of 410 patients were included in the study. The mean morcellation efficiency was 6.95 & PLUSMN;1.70 g/min. Univariable and multivariable linear regression analysis was performed to identify factors affecting morcellation efficiency. Presence of the "beach ball" effect (small, round prostatic tissue fragments that are fibrotic and difficult to morcellate), the learning curve, resectoscope sheath type, prostate-specific antigen (PSA) density, morcellated tissue weight, and the presence of prostate calcification were found to be independent predictive factors ((3=-1.107, 95% CI:-1.59 to-0.55, p<0.001; (3=-0.514, 95% CI:-0.85 to-0.17, p=0.003; (3=-0.394, 95% CI:-0.65 to-0.13, p=0.003; (3=-0.302, 95% CI:-0.59 to-0.09, p=0.043; (3=0.062, 95% CI: 0.05 to 0.06, p<0.001; (3=-0.329, 95% CI:-0.55 to-0.10, p=0.004; respectively).Conclusions: This study reports that presence of the beach ball effect, the learning curve, small resectoscope sheath, PSA density, and presence of prostate calcification negatively affect morcellation efficiency. On the contrary, morcellated tissue weight has a linear relationship with morcellation efficiency.

Keywords

Author Keywords

Benign prostatic hyperplasia, Efficiency, Holmium laser, Morcellation

Effect of the Ureteral Access Sheath Size on Acute Kidney Injury Biomarkers in Retrograde Intrarenal Surgery: A Prospective, Randomized Study

By

Aykanat, IC (Aykanat, Ibrahim Can) [1] ; Balci, M (Balci, Melih) [2] ; Kilinckaya, MF(Kilinckaya, Muhammed Fevzi) [3] ; Akdemir, S (Akdemir, Serkan) [4] ; Senel, C (Senel, Cagdas) [5] ; Guzel, O (Guzel, Ozer) [2] ; Aslan, Y (Aslan, Yilmaz) [2] ; Turhan, T (Turhan, Turan) [6] ; Arslan, M (Arslan, Murat) [4] ; Guneri, C (Guneri, Cagri) [7] ; 

 (provided by Clarivate) 

Source

UROLOGIA INTERNATIONALIS

Volume107Issue6Page564-569

DOI10.1159/000529688

Published

JUN 2023

Early Access

MAR 2023

Indexed

2023-04-02

Document Type

Article

Abstract

Introduction: The aim of the study was to investigate the effect of the diameter of the ureteral access sheath (UAS) used during RIRS on kidney injury based on acute kidney injury (AKI) biomarkers. Methods: This prospectively randomized controlled study included a total of 125 patients divided into three groups: group 1 (n = 52) in which a 12/14 Fr UAS was used, group 2 (n = 52) in which a 9.5/11.5 Fr UAS was used, and group 3 (n = 21) that was designed as the control group with no urogenital disease history. Urine samples were collected preoperatively and at the postoperative second and 24th hours after surgery and analyzed for AKI using the urinary kidney injury molecule-1 (uKIM-1), N-acetyl-ss-D-glucosaminidase, and neutrophil gelatinase-associated lipocain biomarkers. Results: In group 1, there was no statistical change in any of the three AKI biomarkers at the postoperative second or 24th hour compared to the preoperative period. In group 2, the values of all three AKI biomarkers were statistically significantly increased at the postoperative second and 24th hours compared to the preoperative period while no statistical difference was observed between the two postoperative evaluation times. At the postoperative second hour, the uKIM-1 value was statistically significantly higher in group 2 compared to group 1 (p = 0.043). Conclusions: The results of our study showed that AKI was not observed in RIRS performed with a 12/14 Fr UAS while the use of a 9.5/11.5 Fr UAS resulted in AKI according to the assessment of the related biomarkers.

Keywords

Author Keywords

Retrograde intrarenal surgery, Kidney stone, Renal injury, Ureteral access sheath, Acute kidney injury biomarkers

Comparison of Posterior and Antero-Lateral Renal Tumors in Retroperitoneal Laparoscopic Partial Nephrectomy: A Propensity Score Matching Analysis

By

Anil, H (Anil, Hakan) [1] ; Yildiz, A (Yildiz, Ali) [2] ; Güzel, A (Guzel, Ahmet) [3] ; Akdemir, S (Akdemir, Serkan) [4] ; Karamik, K (Karamik, Kaan) [5] ; Arslan, M (Arslan, Murat) [2]

 (provided by Clarivate) 

Source

JOURNAL OF KIDNEY CANCER AND VHL

Volume10Issue3Page9-16

DOI10.15586/jkcvhl.v10i3.273

Published

2023

Indexed

2023-07-26

Document Type

Article

Abstract

This study aimed to compare the antero-lateral and posterior localized renal masses in laparoscopic partial nephrectomy with the retroperitoneal approach in terms of operative, functional, and oncological outcomes. Patients who underwent retroperitoneal laparoscopic partial nephrec-tomy by a single surgeon between January 2013 and January 2021 were included in the study. A one-to-one propensity score matching (PSM) analysis was conducted to obtain two balanced groups. The patients were divided into two groups as posterior and antero-lateral according to the localization of the mass. A total of 239 patients were included in the PSM analysis, with 65 patients allocated to each group. The mean operative time was 79.2 & PLUSMN; 11.2 min in the posterior group, while it was 90.0 & PLUSMN; 11.6 min in the antero-lateral group (P < 0.001). Warm ischemia time was 15.9 & PLUSMN; 2.4 min in the posterior group and 18.6 & PLUSMN; 2.7 min in the antero-lateral group (P < 0.001). The median decrease in eGFR at 1 year was 4.8 (IQR, 2.9-6.9) mL/min in the posterior group and 5.0 (IQR, 2.8-11) mL/min in the antero-lateral group (P = 0.219). The warm isch-emia time and clamping technique were found to be

Keywords

Author Keywords

Anterior laparoscopy, Partial nephrectomy, Posterior renal masses

Comparison of Perioperative Outcomes and Urethral Complications Between Using 24-French and 26-French Resectoscope Sheaths in Holmium Laser Enucleation of the Prostate

By

Yildiz, A (Yildiz, Ali) [1] ; Akdemir, S (Akdemir, Serkan) [2] ; Anil, H (Anil, Hakan) [3] ; Guzel, A (Guzel, Ahmet) [4] ; Arslan, M (Arslan, Murat) [1]

 (provided by Clarivate) 

Source

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI

Volume60Issue2Page127-132

DOI10.4274/haseki.galenos.2022.8104

Published

MAR 2022

Indexed

2022-04-24

Document Type

Article

Abstract

Aim: Although the 26F resectoscope is frequently used in transurethral prostatectomy, there are some concerns with high-caliber shafts. We compared 24F and 26F resectoscope used for Holmium Laser Enucleation of the Prostate (HoLEP) in terms of effects on postoperative urethral complications and perioperative outcomes.

Methods: Data from patients undergoing HoLEP from 2017 to 2021 was retrospectively analyzed. All surgeries were completed by a single surgeon. The patients were divided into one of two groups according to the resectoscope diameter (24F or 26F). All patients were followed up for urethral complications for 12 months. Perioperative outcomes and urethral complications were compared between the groups.

Results: The study included 301 patients. The mean age of patients was 68.5 +/- 8.3 and 69.1 +/- 8.6 for the 26F group (n=180) and the 24F group (n=121), respectively (p=0.608). A total of seven in the 26F group (3.8%) and 3 patients in the 24F group (2.4%) had postoperative urethral stricture (US) (p=0.503). Besides, 2 patients (26F) and 1 patient (24F) had postoperative bladder neck contracture (BNC) (p=0.807). The operation efficiency was 1.25 g/min in the 26F group and 1.17 g/min in the 24F group (p=0.005).

Conclusion: The use of 24F or 26F RS was not shown to cause statistically significant differences in the incidence of US and BNC during the 12-month follow-up. The use of the 24F RS significantly reduces surgical and morcellation efficiency.

Keywords

Author Keywords

Urethral structure, Holmium laser enucleation of the prostate (HoLEP), Prostatic hyperplasia, Complications

Comparison of holmium laser enucleation with bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia: Results of a multicentre study

By

Tuncel, A (Tuncel, Altug) [1] ; Aykanat, C (Aykanat, Can) [2] ; Akdemir, S (Akdemir, Serkan) [3] ; Oksay, T (Oksay, Taylan) [4] ; Arslan, M (Arslan, Murat) [5] ; Basboga, S(Basboga, Serdar) [1] ; Aslan, Y (Aslan, Yilmaz) [1] ; Balci, M (Balci, Melih) [1] ; Guzel, O(Guzel, Ozer) [1]

 (provided by Clarivate) 

Source

ANDROLOGIA

Volume54Issue6

DOI10.1111/and.14420

Article Number

e14420

Published

JUL 2022

Early Access

MAR 2022

Indexed

2022-03-24

Document Type

Article

Abstract

To assess the efficacy and morbidity of the holmium laser enucleation of the prostate and bipolar transurethral enucleation of the prostate in patients with benign prostatic hyperplasia. The study included 60 (55%) and 49 (45%) patients who underwent laser and bipolar enucleation of the prostate respectively. According to the perioperative data, except for length of hospital stay and enucleated prostate weight, all the remaining parameters were similar between the groups. There were significant differences between the preoperative and the postoperative third and 12th month voiding parameters in both groups. In the laser group, the maximum urine flow rate value was better than the bipolar group at the postoperative third and 12th months. However, we did not find any statistically significant difference between the groups in terms of the serum prostate-specific antigen level, International Prostate Symptom Score and postvoid residual urine volume at the postoperative third and 12th months. Our results show that both laser and bipolar techniques are effective minimally invasive surgical treatment options for men with benign prostatic hyperplasia. When compared to bipolar technique, laser technique provides shorter hospital stay, more prostatic tissue enucleation and better maximum urine flow rate values.

Keywords

Author Keywords

Bipolar enucleation, Holmium, Prostate treatment

Holmium Laser Enucleation, Laparoscopic Simple Prostatectomy, or Open Prostatectomy: The Role of the Prostate Volume in terms of Operation Time

By

Gunseren, KO (Gunseren, Kadir Omur) [1] ; Akdemir, S (Akdemir, Serkan) [2] ; Ciçek, MC (cicek, Mehmet Cagatay) [1] ; Yildiz, A (Yildiz, Ali) [3] ; Arslan, M (Arslan, Murat) [3] ; Yavascaoglu, I (Yavascaoglu, Ismet) [1] ; Vuruskan, H (Vuruskan, Hakan) [1]

 (provided by Clarivate) 

Source

UROLOGIA INTERNATIONALIS

Volume105Issue3-4Page285-290

DOI10.1159/000511637

Published

FEB 2021

Early Access

NOV 2020

Indexed

2020-12-09

Document Type

Article

Abstract

Introduction: To compare the prostate removal speeds of 3 enucleation techniques and to evaluate how the operating times change depending on the prostate volume. Methods: Medical records of patients with 80-g or larger prostates who underwent holmium laser enucleation of the prostate (HoLEP), laparoscopic simple prostatectomy (LSP), or open prostatectomy (OP) due to medical treatment-resistant benign prostatic hyperplasia (BPH) were reviewed retrospectively. Patients were classified into 3 groups according to the surgical procedure. Age, BMI, prostate weights, total operation times, prostate removal speeds, hospitalization and catheterization days, complications, and improvements on functional outcomes in the 3rd month of follow-up were compared between groups. In addition, the association between prostate weight and total operation time was analyzed for each group. Results: HoLEP, LSP, and OP groups consisted of 60, 61, and 37 patients, respectively. While HoLEP was similar to OP in terms of prostate removal speed and total operation time, LSP was statistically slower and required more operation time than HoLEP and OP. There was a relationship between prostate weight and total operation time only in HoLEP. Conclusion: LSP, one of the enucleation techniques in the treatment of large prostates, was slower and required more operation time than HoLEP and OP in terms of total operation time and prostate removal speed. HoLEP seems going to be the fastest candidate for the rapid removal of large prostates in the future.

Keywords

Author Keywords

Prostate, Benign prostatic hyperplasia, Adenomectomy, Holmium laser enucleation of the prostate, Laparoscopic open prostatectomy

Watt matters: Safety and efficacy of using a 140-W high-powered holmium laser for enucleation of the prostate (HoLEP)

By

Yildiz, A (Yildiz, Ali) [1] ; Akdemir, S (Akdemir, Serkan) [2] ; Anil, H (Anil, Hakan) [3] ; Arslan, M (Arslan, Murat) [1]

 (provided by Clarivate) 

Source

TURKISH JOURNAL OF UROLOGY

Volume47Issue2Page131-136

DOI10.5152/tud.2021.20558

Published

MAR 2021

Indexed

2021-04-17

Document Type

Article

Abstract

Objective: This study aimed to assess the perioperative and the 12-month efficacy and safety of 140 W high-powered holmium laser for enucleation of the prostate (HP-HoLEP) for the treatment of benign prostatic obstruction.

Material and methods: The data of 540 patients who underwent HoLEP by a single surgeon were analyzed retrospectively. Preoperative evaluation included a physical examination with a digital rectal examination, measurement of maximum urinary flow rate (Q(max)), postvoid residual volume (PVR) and prostate volume by transabdominal ultrasonography, serum prostate-specific antigen (PSA), international prostate symptom score (I-PSS) and international index of erectile function-5 (IIEF-5) questionnaires, and urine analysis. Morcellation, enucleation, and operation efficiencies were calculated with the resected weight divided by morcellation, enucleation, and operative times, respectively. The patients were reassessed at 1, 3, 6, and 12 months after surgery by I-PSS, IIEF-5, Q(max), PSA, and the occurrence of complications.

Results: The mean operative time was 65.2 +/- 20.9 minutes. The mean enucleation time and efficiency were 53 +/- 15.1 minutes and 1.72 +/- 0.4 g/min, respectively. The mean morcellation time and efficiency were 12.3 +/- 15.1 minutes and 7.4 +/- 3.2 g/min respectively. Clavien grade 1 complications were observed in 102 (18.9%) patients, Clavien grade 2 complications in 20 (3.7%) patients, and Clavien grade 3b complications in 23 (5.4%) patients. I-PSS, Q(max), and IIEF-5 at postoperative 1, 3, 6, and 12 months were significantly better than baseline results.

Conclusion: Our study demonstrated that 140 W HP-HoLEP can be performed with high enucleation efficiency, low perioperative and postoperative complication rates, and excellent functional results.

Keywords

Author Keywords

Holmium laser for enucleation of the prostate140 watt

Extraperitoneal Laparoscopic Versus Transperitoneal Robot-Assisted Laparoscopic Approaches for Extended Pelvic Lymph Node Dissection During Radical Prostatectomy

By

Yildiz, A (Yildiz, Ali) [1] ; Anil, H (Anil, Hakan) [2] ; Akdemir, S (Akdemir, Serkan) [3] ; Aksaray, EE (Aksaray, Eren Erdi) [4] ; Ates, M (Ates, Mutlu) [4] ; Arslan, M (Arslan, Murat) [1]

 (provided by Clarivate) 

Source

JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES

Volume32Issue4Page355-359

DOI10.1089/lap.2021.0174

Published

APR 1 2022

Early Access

MAY 2021

Indexed

2021-05-20

Document Type

Article

Jump to

Abstract

Background: We aim to directly compare the feasibility and safety of extended pelvic lymph node dissection (PLND) during transperitoneal robotic-assisted radical prostatectomy (Tp-RARP) and extraperitoneal laparoscopic radical prostatectomy (Ep-LRP).

Materials and Methods: We retrospectively identified the prospectively maintained database records of 162 patients diagnosed with prostate cancer (PC) who underwent Ep-LRP or Tp-RARP with extended PLND. Patients with risk of nodal metastases over 5% according to Briganti nomogram received extended PLND. All data analyzed in this study were based on the documentation in our PC database including age, body mass index, Charlson comorbidity index score, preoperative prostate-specific antigen, history of abdominal surgery, biopsy Gleason score, total operation time, postoperative pelvic drainage time, pathological results, lymph node yield (LNY), percentage lymph node involvement (%LNI), and perioperative complications. Patients were followed up for biochemical recurrence in the postoperative period.

Results: Eighty-two of the 162 enrolled patients were in group 1 (Ep-LRP+PLND) and 80 were in group 2 (Tp-RARP+PLND). There were no statistically significant differences between the groups regarding preoperative demographics and clinical characteristics. The median LNY was 17 (range 8-27) and 17.5 (range 10-29) in groups 1 and 2, respectively, and no statistically significant difference was found. There was no significant difference between the groups in terms of biochemical recurrence-free survival with mean follow-up of 44.8 months after radical surgery.

Conclusion: Our results support the view that extended PLND through the Ep-LRP approach is a feasible and safe procedure without compromising oncological efficacy compared with a similar template attempted during Tp-RARP. Clinical Trial Registration number is 01/21-2.

Keywords

Author Keywords

Prostate cancer, Lymph node dissection, Extraperitoneal, Transperitoneal

Safety and Efficacy of High-Powered Holmium Laser Enucleation of the Prostate within 1-3 Weeks Following Prostate Biopsy

By

Yildiz, A (Yildiz, Ali) [1] ; Akdemir, S (Akdemir, Serkan) [2] ; Anil, H (Anil, Hakan) [3] ; Arslan, M (Arslan, Murat) [1]

 (provided by Clarivate) 

Source

UROLOGIA INTERNATIONALIS

Volume105Issue9-10Page852-857

DOI10.1159/000514422

Published

SEP 2021

Early Access

MAR 2021

Indexed

2021-04-16

Document Type

Article

Jump to

Abstract

Purpose: We aim to document the feasibility, perioperative safety, and the 12-month efficacy of holmium laser enucleation of the prostate (HoLEP) within 1-3 weeks following transrectal ultrasound (TRUS)-guided prostate biopsy. Methods: Data of the patients who underwent HoLEP following TRUS-guided prostate biopsy between March 2017 and July 2020 were analyzed retrospectively. Patients were divided into 2 groups: group 1 had undergone HoLEP in the early period after TRUS-guided prostate biopsy, while group 2 patients were biopsy-naive ("control group"). All patients were assessed preoperatively by a physical examination with the digital rectal examination; time from biopsy to HoLEP; measurement of Q(max), postvoiding residual volume, and prostate volume by transabdominal ultrasonography; serum prostate-specific antigen level, the International Prostate Symptom Score (IPSS); the International Index of Erectile Function-5 questionnaire; and urine analysis. The patients were reevaluated at 3- and 12-month follow-up. Perioperative and postoperative complications were documented according to the modified Clavien-Dindo System. Results: Group 1 comprised 66 patients with a mean age of 67.3 +/- 6.7 (range, 53-86) years, and group 2 comprised 114 patients with a mean age of 69.4 +/- 9.4 (range, 36-95) years. The operation, enucleation, and morcellation efficiencies were not statistically significant between the groups. Preoperative Q(max) and IPSS values were significantly improved after HoLEP surgery in the 3rd and 12th months in all patients. Our complication rates were similar in both groups. Conclusion: High-powered HoLEP using 140 W energy within 1-3 weeks following TRUS-guided prostate biopsy is a feasible procedure with high enucleation efficiency, low perioperative morbidity, and excellent functional outcomes. A recent TRUS-guided prostate biopsy is not a contraindication to HoLEP.

Keywords

Author Keywords

Holmium laser enucleation of the prostate, Benign prostatic hyperplasia, Transrectal prostate biopsy, High-power holmium laser enucleation of the prostate, Transurethral enucleation

Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction

By

Karabakan, M (Karabakan, Mehmet) [1] ; Keskin, E (Keskin, Ercument) [2] ; Akdemir, S(Akdemir, Serkan) [3] ; Bozkurt, A (Bozkurt, Aliseydi) [2]

 (provided by Clarivate) 

Source

INTERNATIONAL BRAZ J UROL

Volume43Issue2Page317-324

DOI10.1590/S1677-5538.IBJU.2016.0376

Published

MAR-APR 2017

Indexed

2017-04-06

Document Type

Article

Abstract

Objective: To investigate the effect of a 5mg daily tadalafil treatment on the ejaculation time, erectile function and lower urinary tract symptoms (LUTS) in patients with erectile dysfunction.

Materials and Methods: A total of 60 patients diagnosed with erectile dysfunction were retrospectively evaluated using the international index of erectile function questionnaire- 5 (IIEF-5), intravaginal ejaculatory latency time (IELT) and international prostate symptoms scores (IPSS). After the patients were treated with 5mg tadalafil once a day for three months, their erection, ejaculation and LUTS were assessed again. The fasting levels of blood glucose, total testosterone, low-density lipoprotein cholesterol, highdensity lipoprotein cholesterol and total cholesterol were measured. The independentsamples t-test was used to compare the pre-and post-treatment scores of the patients.

Results: The mean age of the 60 participants was 50.4 +/- 7.9 and the mean baseline serum total testosterone, total cholesterol, and fasting blood sugar were 444.6 +/- 178.6 ng dL-1, 188.7 +/- 29.6mg/dL-1,104 (80-360) mg dL-1, respectively. The mean baseline scores were 2.2 +/- 1.4 min for IELT, 9.5 +/- 3.7 for IIEF-5 and 14.1 +/- 4.5 for IPSS. Following the three-month daily 5mg tadalafil treatment, the scores were found to be 3.4 +/- 1.9 min, 16.1 +/- 4.7, and 10.4 +/- 3.8 for IELT, IIEF and IPSS, respectively. When the baseline and post-treatment scores were compared, a statistically significant increase was observed in the IELTs and IIEF-5 values whereas there was a significant decrease in IPSS (p<0.01).

Conclusion: A daily dose of 5mg tadalafil can be safely used in the treatment of erectile dysfunction and LUTS, that prolongs the ejaculatory latency time.

Keywords

Author Keywords

Tadalafil, Ejaculation, Erectile dysfunction, Therapeutics

Multi-agent Based File Replication and Consistency Management

By

Akdemir, S (Akdemir, Serkan) [1] ; Erdogan, N (Erdogan, Nadia) [2]

Edited by

Oliveira, E (Oliveira, E) ; Gama, J (Gama, J) ; Vale, Z (Vale, Z) ; Cardoso, HL (Cardoso, HL)

 (provided by Clarivate) 

Source

PROGRESS IN ARTIFICIAL INTELLIGENCE (EPIA 2017)

Volume10423Page727-738

DOI10.1007/978-3-319-65340-2_59

Book Series

Lecture Notes in Artificial Intelligence

Published

2017

Indexed

2018-12-28

Document Type

Proceedings Paper

Conference

Meeting18th EPIA Conference on Artificial Intelligence (EPIA)

LocationUniv Porto, Fac Engn, Porto, PORTUGAL

DateSEP 05-08, 2017

SponsorsEPIA; Univ Porto, Artificial Intelligence & Comp Sci Lab; INESC TEC, Lab Artificial Intelligence & Decis Support; Inst Engn Polytechn Porto, Intelligent Engn & Comp Adv Innovat & Dev Res Grp

Abstract

Replication is a well-known technique in distributed systems. Replication can reduce data access latency, enhance and optimize the availability and reliability of the entire system. The existence of multiple instances of data however causes additional issues. The main issue is consistency of data. In this paper we present a multi-agent based approach for file replication and consistency management. We describe the design of a multi-agent system using the JADE platform. The system presents a multi-agent based communication framework that enables the replication and maintenance of files.

Differences in Poly(ADP-ribose) Polymerase1-(PARP1-) and Proliferative Cell Nuclear Antigen (PCNA) Immunoreactivity in Patients Who Experienced Successful and Unsuccessful Microdissection Testicular Sperm Extraction Procedures

By

Akarsu, S (Akarsu, Suleyman) [1] ; Büke, B (Buke, Baris) [2] ; Gürgen, SG (Gurgen, Seren Gulsen) [3] ; Akdemir, S (Akdemir, Serkan) [4] ; Gode, F (Gode, Funda) [1] ; Bicer, M (Bicer, Merve) [5] ; Tekindal, MA (Tekindal, Mustafa Agah) [6] ; Isik, AZ (Isik, Ahmet Zeki) [1]

 (provided by Clarivate) 

Source

UROLOGY JOURNAL

Volume14Issue5Page5018-5022

Published

SEP-OCT 2017

Indexed

2018-01-09

Document Type

Article

Abstract

Purpose: The aim of this study is to evaluate expression of deoxyribonucleic acid (DNA) synthesis and repair markers in testicular tissues of azoospermic men in whom sperm retrieval could and could not be achieved as a result of microdissection testicular sperm extraction (micro-TESE) procedure.

Materials and Methods: In this prospective cohort study, testicular tissues were retrieved from 60 Non-obstrucrive Azoospermia (NOA) patients who underwent micro-TESE procedure. These patients were divided into two groups: micro-TESE positive group, which included 30 NOA patients from whom sperm could be extracted via micro-TESE procedure; and micro-TESE negative group, which included 30 NOA patients from whom sperm retrieval could not be achieved via micro-TESE procedure. Expression and distribution patterns of poly(ADP-ribose) polymerase-1 (PARP-1) and proliferative cell nuclear antigen (PCNA) in extracted tissues were assessed by immunohistochemical staining to reveal any differences in DNA synthesis and repair between the two groups.

Results: Micro-TESE positive group exhibited significantly stronger immunoreactivity for both PCNA and PARP1 (P =.001 and P =.001 respectively). The results of this study reveal that both DNA synthesis and repair markers were expressed strongly in patients who experienced successful micro-TESE procedure.

Conclusion: Although further studies are needed to support these findings, PARP-1 and PCNA expression in testicular tissues of NOA patients could be promising predictive factors for micro-TESE procedure success.

Keywords

Author KeywordsAzoospermia Micro-Tese PCNAPARP-1

The Effect of Ejaculation Frequency on Serum Prostate-Specific Antigen Level

By

Karabakan, M (Karabakan, Mehmet) [1] ; Akdemir, S (Akdemir, Serkan) [2] ; Akdemir, AÖ (Akdemir, Alp Ozgur) [3] ; Öztekin, ÇV (Oztekin, Cetin Volkan) [3] ; Güzer, Ö (Guzel, Ozer) [3] ; Gökkaya, CS (Gokkaya, Cevdet Serkan) [3] ; Çetinkaya, M (Cetinkaya, Mesut) [3]

Source

JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM

Volume5Issue2Page56-59

DOI10.5152/jarem.2015.685

Published

AUG 2015

Indexed

2015-09-14

Document Type

Article

Abstract

Objective: Serum prostate-specific antigen (PSA) levels are very important in the diagnosis of prostate cancer. Besides prostate cancer, PSA levels can also be increased by cystoscopy, prostate biopsy, prostatitis, and manipulation. There are also studies reporting that ejaculation affects serum PSA levels. In this study, we aimed to investigate the effects of ejaculation frequency on serum PSA level.

Methods: A total of 135 male patients aged in the range of 48-69 years who presented with lower urinary tract symptoms at the urology outpatient clinic between October 2009 and August 2012 were included in the study. Three groups divided according to ejaculation frequency (Group 1, Group 2, and Group 3) were compared by total and free PSA (t/f PSA) values, age, International Prostate Symptom Score (IPSS), prostate volumes, and PSA density (PSAD).

Results: There was no significant difference between t/f PSA values, age, IPSS, prostate volumes, and PSAD values of the groups.

Conclusion: In our study, ejaculation frequency was found to have no effect on serum PSA levels.

Keywords

Author Keywords

Ejaculation frequency, Prostate specific antigen, Ejaculation

Neurogenic Bladder Due to Neuro-Behcet Disease: A Case Report

By

Karabakan, M (Karabakan, Mehmet) [1] ; Guzel, Ö (Guzel, Ozer) [2] ; Erkmen, AE(Erkmen, Akif Ersoy) [2] ; Salar, R (Salar, Remzi) [2] ; Bozkurt, A (Bozkurt, Aliseydi) [1] ; Akdemir, S (Akdemir, Serkan) [2]

 (provided by Clarivate) 

Source

JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM

Volume4Issue1Page28-30

DOI10.5152/jarem.2014.427

Published

APR 2014

Indexed

2014-04-01

Document Type

Article

Abstract

Behcet's disease is defined as a systemic vasculitis that has unknown etiology and characterized by recurrent oral aphthous ulcers, skin rashes, eye involvement (iridocyclitis with hypopyon), and genital ulcers. Involvement of the bladder in neuro-Behcet disease is quite rare, and its incidence has been reported as approximately 0.07%. Our case had Behcet disease for 20 years and lower urinary tract symptoms with urinary incontinence for 2 years. Anti-cholinergic treatment was initiated after the urodynamic examination. This case report has been presented to emphasize the importance of diagnosis in Neuro-Behcet disease with bladder involvement.

Keywords

Neurogenic bladderneuro-Behcet disease

Primary Renal Carcinoid Tumor: A Case Report

By

Karabakan, M (Karabakan, Mehmet) [1] ; Akdemir, S (Akdemir, Serkan) [1] ; Akdemir, AÖ (Akdemir, Alp Ozgur) [1] ; Kulaçoglu, S (Kulacoglu, Sezer) [2] ; Çetinkaya, M(Cetinkaya, Mesut) [1]

Source

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE

Volume4Page414-416Supplement4

DOI10.4328/JCAM.2411

Published

AUG 2013

Indexed

2013-08-01

Document Type

Article

Abstract

Primary renal carcinoid tumor is an extremely uncommon neoplasm that arises from neuroendocrine cells. As it is extremely uncommon, its immunohistochemical characteristics have not been clearly determined. In this case, a 23-year-old male patient was incidentally identified with right renal mass. Right radical nephrectomy was performed. Postoperative 22-month follow-up showed no metastasis or recurrence.

Keywords

Author KeywordsNeurendocrine TumorsRenal CancerNephrectomy

Keywords PlusKIDNEY

A Rare Case Report: Plasmacytoid Urothelial Carcinoma of the Urinary Bladder

By

Karabakan, M (Karabakan, Mehmet) [1] ; Akdemir, S (Akdemir, Serkan) [2] ; Akdemir, AÖ (Akdemir, Alp Ozgur) [2] ; Güzel, Ö (Guzel, Ozer) [2] ; Çolak, A (Colak, Aysel) [3]

 (provided by Clarivate) 

Source

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE

Volume4Page539-541Supplement5

DOI10.4328/JCAM.2625

Published

OCT 2013

Indexed

2013-10-01

Document Type

Article

Abstract

Plasmacytoid urothelial carcinoma is a rare variant of urothelial carcinoma and approximately 70 cases have been reported in the literature. This histologic variant has limited data. 46-year-old male patient who is presented with complaints about hematuria underwent transurethral resection. During the microscopic examination, specimens had plasmacytoid appearances. With chemotherapy, gemcitabine and cisplatin were administered to the patient. In this article, the diagnosis and thereatment of plasmacytoid urothelial carcinoma case that has invasion and lymphnode positivity is presented.

Keywords

Author Keywords

Plasmacytoid Urothelial Carcinoma Hematuria Urinary Bladder

Bilimsel Kuruluşlara Üyelikler :

1. European Association of Urology (EAU)
2. Türk Üroloji Derneği
3. Türk Endoüroloji Derneği
4. Türk Tabipler Birliği